| Literature DB >> 31571887 |
Hiroshi Matsuda1, Kota Yokoyama2, Noriko Sato2, Kengo Ito3, Kiyotaka Nemoto4, Hiroshi Oba5, Haruo Hanyu6, Hidekazu Kanetaka6, Sunao Mizumura7, Shin Kitamura8, Hitoshi Shinotoh9, Hitoshi Shimada9, Tetsuya Suhara9, Hitoshi Terada10, Tomoya Nakatsuka10, Shinobu Kawakatsu11, Hiroshi Hayashi12, Takashi Asada13, Tetsutaro Ono14, Tomoaki Goto14, Keiko Shigemori14.
Abstract
BACKGROUND: The differential diagnosis of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) is particularly important because DLB patients respond better to cholinesterase inhibitors but sometimes exhibit sensitivity to neuroleptics, which may cause worsening of clinical status. Antemortem voxel-based morphometry (VBM) using structural MRI has previously revealed that patients with DLB have normal hippocampal volume, but atrophy in the dorsal mesopontine area.Entities:
Keywords: Alzheimer’s disease; MRI; dementia with Lewy bodies; voxel-based morphometry
Year: 2019 PMID: 31571887 PMCID: PMC6757232 DOI: 10.2147/NDT.S222966
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Subjects Data
| Center | Number Of Patients | DLB | AD | MR Scanner | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Age (Years) | MMSE | Men | Women | Age (Years) | MMSE | |||
| Tokyo (Shinjuku) | 60 | 15 | 18 | 78.5±5.8 | 20.6±6.0 | 8 | 19 | 78.8±5.3 | 21.3±3.8 | Siemens Avanto 1.5T |
| Sakura | 84 | 30 | 29 | 75.9±6.5 | 21.6±3.8 | 6 | 19 | 80.4±3.8 | 19.2±3.4 | Philips Gyroscan 1.5T |
| Yamagata | 270 | 24 | 36 | 81.5±6.4 | 17.7±5.2 | 43 | 167 | 80.5±5.4 | 18.1±4.7 | Siemens Symphony 1.5T |
| Tokyo (Kodaira) | 51 | 11 | 16 | 76.4±6.6 | 18.2±5.7 | 9 | 15 | 75.3±7.8 | 22.0±3.8 | Philips Achieva 3.0T, Siemens Verio 3.0T |
| Obu | 45 | 7 | 9 | 78.2±7.4 | 20.1±7.1 | 12 | 17 | 79.1±6.6 | 17.9±5.4 | Philips Ingenia 1.5T |
| Tsukuba | 7 | 3 | 0 | 76.0±8.9 | 24.0±1.7 | 1 | 3 | 73.0±8.1 | 13.5±6.0 | Siemens Avanto 1.5T |
| Tokyo (Itabashi) | 8 | 2 | 3 | 78.2±4.0 | 20.6±6.3 | 2 | 1 | 83.3±4.5 | 23.0±1.7 | GE Signa HDxt 3.0T, GE Genesis Signa 1.5T |
| Tokyo (Oota) | 51 | 7 | 15 | 77.5±7.3 | 20.0±5.3 | 8 | 21 | 77.8±7.7 | 19.2±5.0 | TOSHIBA Excelart Vantage 1.5T |
| Kawasaki | 27 | 4 | 5 | 75.8±4.6 | 20.8±5.4 | 6 | 12 | 81.8±7.3 | 18.6±5.2 | Philips Gyroscan Intera 1.5T |
| Chiba | 21 | 4 | 1 | 73.0±6.2 | 22.6±1.9 | 4 | 12 | 69.9±9.4 | 18.2±5.7 | Philips Gyroscan Intera 1.5T |
| Total | 624 | 107 | 132 | 78.0±6.7 | 19.8±5.4 | 99 | 286 | 79.3±6.5 | 18.7±4.8 | |
Abbreviations: DLB, dementia with Lewy bodies; AD, Alzheimer’s disease.
Figure 1VOIs in the VSRAD® software program. (A) VOI in medial temporal lobe structures. (B) VOI in the dorsal brain stem.
Comparison Of Single Index Values For Characterizing Atrophy In The Target VOIs Between DLB And AD
| Index | DLB (n=239) | AD (n=385) |
|---|---|---|
| MTL_Z | 1.73±0.88 | 2.44±1.05** |
| DBS_Z_gray | 0.57±0.23* | 0.53±0.25 |
| DBS_Z_white | 0.67±0.57 | 0.65±0.72 |
| DBS_Z_gray_ratio | 0.44±0.32** | 0.28±0.20 |
| DBS_Z_white_ratio | 0.47±0.48** | 0.30±0.34 |
Notes: *P<0.05, **P<0.001.
Abbreviations: VOI, volume of interest; DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; MTL, medial temporal lobe; DBS, dorsal brain stem.
Discrimination Performance Of DLB And AD Using Single Indices
| Index | DLB Cutoff | Training Data (n=414) | Test Data (n=210) | |||||
|---|---|---|---|---|---|---|---|---|
| AUC | Sensitivity | Specificity | Accuracy | Sensitivity | Specificity | Accuracy | ||
| MTL_Z | <2.19 | 0.72 | 75.7% | 59.2% | 65.2% | 75.9% | 43.9% | 57.1% |
| DBS_Z_gray | ≥0.34 | 0.54 | 87.5% | 22.5% | 46.4% | 86.2% | 17.9% | 46.2% |
| DBS_Z_white | ≥0.32 | 0.56 | 69.1% | 46.2% | 54.6% | 72.4% | 30.9% | 48.1% |
| DBS_Z_gray_ratio | ≥0.27 | 0.68 | 68.4% | 60.7% | 63.5% | 70.1% | 50.4% | 58.6% |
| DBS_Z_white_ratio | ≥0.33 | 0.66 | 50.7% | 75.6% | 66.4% | 59.8% | 55.3% | 57.1% |
Figure 2Decision tree for differentiation of DLB and AD using VBM results in the training data set. Below each node, the numbers of AD (left) and DLB (right) patients are shown. The class of AD or DLB as the classification result is shown at the center of each node. In this decision tree, the condition classified as DLB corresponds to the terminal node on the right end, and “MTL_Z <2.185 and DBS_Z_white_ratio ≥0.195 and DBS_Z_gray_ratio” is the cutoff.
Discrimination Performance Of DLB And AD Using Multiple Indices
| DLB Cutoff | Training Data (n=414) | Test Data (n=210) | ||||
|---|---|---|---|---|---|---|
| Sensitivity | Specificity | Accuracy | Sensitivity | Specificity | Accuracy | |
| MTL_Z < 2.185 & DBS_Z_gray_ratio ≥ 0.195 & DBS_Z_white_ratio ≥ 0.195 | 57.2% | 82.8% | 73.4% | 56.3% | 68.3% | 63.3% |
| MTL_Z < 2.0 & DBS_Z_gray_ratio ≥ 0.2 & DBS_Z_white_ratio ≥ 0.2 | 52.0% | 84.4% | 72.5% | 50.6% | 75.6% | 65.2% |
Association Of Single Index Values With Core Clinical Features In DLB
| Index | Core Clinical Features | |||||||
|---|---|---|---|---|---|---|---|---|
| Fluctuating Cognition | Visual Hallucination | Parkinsonism | REM Sleep Behaviour Disorder | |||||
| Positive (n=56) | Negative (n=64) | Positive (n=96) | Negative (n=24) | Positive (n=72) | Negative (n=48) | Positive (n=55) | Negative (n=65) | |
| MTL_Z | 1.75±0.94 | 1.63±0.77 | 1.71±0.78 | 1.58±1.12 | 1.74±0.86 | 1.59±0.85 | 1.63±0.96 | 1.73±0.77 |
| DBS_Z_gray | 0.59±0.24 | 0.59±0.25 | 0.57±0.23 | 0.65±0.30 | 0.62±0.25 | 0.54±0.22 | 0.57±0.22 | 0.60±0.27 |
| DBS_Z_white | 0.79±0.64 | 0.60±0.63 | 0.66±0.62 | 0.80±0.70 | 0.71±0.67 | 0.64±0.58 | 0.65±0.59 | 0.72±0.68 |
| DBS_Z_gray_ratio | 0.45±0.33 | 0.48±0.34 | 0.42±0.27* | 0.64±0.49 | 0.47±0.34 | 0.46±0.33 | 0.48±0.35 | 0.45±0.32 |
| DBS_Z_white_ratio | 0.56±0.64 | 0.43±0.49 | 0.43±0.44* | 0.71±0.89 | 0.49±0.60 | 0.48±0.51 | 0.48±0.48 | 0.49±0.64 |
Note: *P<0.05.